David C Hastings insider trades: Arbutus Biopharma (ABUS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 4, 2025 | ABUS | ↓ Sell | 22,183 | $3.28 | $73K | Direct | Feb 5, 2025 (1d) |
| Feb 2, 2024 | ABUS | ↓ Sell | 9,593 | $2.31 | $22K | Direct | Feb 5, 2024 (3d) |
| Mar 8, 2018 | SCYX | ↑ Buy | 11,834 | $1.69 | $20K | Direct | Mar 12, 2018 (4d) |
| Jun 21, 2017 | SCYX | ↑ Buy | 20,000 | $1.75 | $35K | Direct | Jun 22, 2017 (1d) |
| Jun 5, 2014 | INCY | ↓ Sell | 200,000 | $52.73 | $10.5M | Direct | Jun 6, 2014 (1d) |
| Feb 18, 2014 | INCY | ↓ Sell | 275,000 | $65.86 | $18.1M | Direct | Feb 18, 2014 (0d) |
| Sep 6, 2013 | INCY | ↓ Sell | 100,000 | $35.16 | $3.5M | Direct | Sep 9, 2013 (3d) |
| Feb 15, 2013 | INCY | ↓ Sell | 100,000 | $22.52 | $2.3M | Direct | Feb 20, 2013 (5d) |
| Jun 9, 2011 | INCY | ↓ Sell | 100,000 | $17.73 | $1.8M | Direct | Jun 10, 2011 (1d) |
| Jul 1, 2010 | INCY | ↑ Buy | 2,000 | $10.24 | $20K | Direct | Jul 6, 2010 (5d) |
| Nov 20, 2008 | INCY | ↑ Buy | 4,000 | $2.36 | $9K | Direct | Nov 21, 2008 (1d) |
| Apr 4, 2006 | INCY | ↑ Buy | 2,500 | $3.60 | $9K | Direct | Apr 5, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David C Hastings's insider trades
David C Hastings is Chief Financial Officer at Arbutus Biopharma (ABUS). Since Apr 4, 2006, David has reported 5 open-market purchases worth $94K and 7 sales worth $36.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (40 filings), option exercises (5 filings), other transactions (2 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABUS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.